Patent 10450606 was granted and assigned to Fred Hutchinson Cancer Research Center on October, 2019 by the United States Patent and Trademark Office.
The present disclosure provides compositions and methods for accurately detecting mutations by uniquely tagging double stranded nucleic acid molecules with dual cyphers such that sequence data obtained from a sense strand can be linked to sequence data obtained from an anti-sense strand when sequenced, for example, by massively parallel sequencing methods.